219A.T JPX
Heartseed, Inc.
1W: -4.4%
1M: +4.1%
3M: +54.6%
YTD: +35.2%
1Y: -24.3%
¥2,680.00 ($16.95)
+101.00 (+3.92%)
Weekly Expected Move ±8.1%
¥2161
¥2370
¥2579
¥2788
¥2997
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥59.0B ($373.1M)
52W Range1365-2790
Volume350,300
Avg Volume378,659
Beta0.54
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKeiichi Fukuda
Employees43
SectorHealthcare
IndustryBiotechnology
IPO Date2024-07-30
Websiteheartseed.jp
5th Floor, Seavans South Building
Tokyo, TY 105-0023
JP
Tokyo, TY 105-0023
JP
+81 3 6665 8068
About Heartseed, Inc.
Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplanted into the heart for patients with severe heart failure. Target diseases include dilated cardiomyopathy, old myocardial infarction, and dilated-phase hypertrophic cardiomyopathy.
Latest News
No recent news
Recent Insider Trades
No insider trades found